Federal contract award
75D30124P00045
THE FOLLOWING VENDORS WERE CONTACTED TO DETERMINE IF SIMILAR REAGENTS COULD BE PROCURED/SOURCED FROM A VENDOR OTHER THAN BIOMERIEUX THAT HAS THE SAME PERFORMANCE SPECIFICATIONS OF THOSE BEING SOUGHT. VENDORS CONTACTED INCLUDED: ABBOTT, THERMO FISHER
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | CDC OFFICE OF ACQUISITION SERVICES |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6640 — Laboratory Equipment and Supplies |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $12.0K |
| Current contract value | $12.0K |
| Potential contract value / ceiling | $12.0K |
| Start date | Aug 20, 2024 |
| Current end date | Sep 11, 2024 |
| Potential end date | Sep 11, 2024 |
| Latest award activity | Feb 25, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Feb 25, 2026 | P00001 | $-736 | BIOMERIEUX'S NUCLISENS REAGENTS TO BE USED ON THEIR SAMPLE EXTRACTION PLATFORMS THAT HAVE BEEN VALIDATED FOR HIV DRUG RESISTANCE: NUCLISENS EASYMAG, EMAG AND THE MINIMAG WHICH ARE USED BY THE MOLECULAR DIAGNOSTIC AND SURVEILLANCE TEAM'S SURVEILLANCE |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.